Cart is empty An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai, has made a major breakthrough in treating a common and challenging form of cancer called diffuse large B-cell lymphoma (DLBCL).
Leave A Comment